CCG
MRK icon

Chatham Capital Group’s Merck MRK Stock Holding History

Chatham Capital Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.94M Buy
46,191
+232
+0.5% +$27.2K 0.76% 37
2026
Q1 		$5.53M Sell
45,959
-184
-0.4% -$21.2K 0.8% 33
2025
Q4 		$4.86M Buy
46,143
+125
+0.3% +$11.7K 0.69% 40
2025
Q3 		$3.86M Sell
46,018
-599
-1% -$49.3K 0.56% 55
2025
Q2 		$3.69M Buy
46,617
+13,730
+42% +$1.09M 0.56% 56
2025
Q1 		$2.95M Buy
32,887
+319
+1% +$29.8K 0.49% 66
2024
Q4 		$3.24M Buy
32,568
+612
+2% +$63.1K 0.53% 60
2024
Q3 		$3.63M Sell
31,956
-11,771
-27% -$1.4M 0.59% 52
2024
Q2 		$5.41M Sell
43,727
-525
-1% -$67.6K 0.95% 32
2024
Q1 		$5.84M Sell
44,252
-224
-0.5% -$27.6K 1.07% 28
2023
Q4 		$4.85M Buy
44,476
+135
+0.3% +$14K 0.98% 28
2023
Q3 		$4.56M Buy
44,341
+2,136
+5% +$230K 1.02% 29
2023
Q2 		$4.87M Buy
42,205
+185
+0.4% +$21K 1.02% 27
2023
Q1 		$4.47M Buy
42,020
+110
+0.3% +$11.9K 1% 32
2022
Q4 		$4.65M Sell
41,910
-133
-0.3% -$13.6K 1.09% 30
2022
Q3 		$3.62M Buy
42,043
+764
+2% +$68.2K 0.89% 34
2022
Q2 		$3.76M Buy
41,279
+436
+1% +$38.7K 0.85% 39
2022
Q1 		$3.35M Buy
40,843
+110
+0.3% +$8.67K 0.65% 49
2021
Q4 		$3.12M Sell
40,733
-1,825
-4% -$145K 0.56% 57
2021
Q3 		$3.2M Sell
42,558
-883
-2% -$67.2K 0.62% 53
2021
Q2 		$3.38M Sell
43,441
-1,389
-3% -$103K 0.65% 49
2021
Q1 		$3.3M Buy
44,830
+435
+1% +$32.1K 0.69% 46
2020
Q4 		$3.46M Sell
44,395
-1,384
-3% -$106K 0.78% 41
2020
Q3 		$3.62M Sell
45,779
-3,799
-8% -$298K 0.89% 38
2020
Q2 		$3.66M Sell
49,578
-151
-0.3% -$11.4K 0.95% 32
2020
Q1 		$3.65M Buy
49,729
+1,446
+3% +$114K 1.08% 29
2019
Q4 		$4.19M Buy
48,283
+125
+0.3% +$10.3K 1.03% 30
2019
Q3 		$3.87M Buy
48,158
+42
+0.1% +$3.37K 0.99% 34
2019
Q2 		$3.85M Buy
+48,116
New +$3.68M 0.97% 32
2015
Q3 		– Sell
-5,665
Closed -$308K – 149
2015
Q2 		$308K Sell
5,665
-1,453
-20% -$81.5K 0.09% 131
2015
Q1 		$390K Buy
7,118
+524
+8% +$29.7K 0.11% 125
2014
Q4 		$357K Hold
6,594
– – 0.11% 132
2014
Q3 		$373K Buy
+6,594
New +$370K 0.12% 124

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Chatham Capital Group's MRK Position: Q2 2026 in Review

Chatham Capital Group increased its Merck (MRK) stake by 0.5% in Q2 2026, buying an estimated $27.2K and bringing the position to 46,191 shares worth $5.94M. The position accounts for 0.76% of the portfolio, ranked #37.

Chatham Capital Group first reported a position in MRK in Q3 2014 and has held it in 33 quarters since. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Chatham Capital Group held 46,191 shares of Merck worth $5.94M as of Q2 2026.
  • Chatham Capital Group bought 232 Merck shares in Q2 2026, an estimated $27.2K.
  • Merck made up 0.76% of Chatham Capital Group's portfolio in Q2 2026, its #37 holding.
  • Chatham Capital Group first reported a position in Merck in Q3 2014 and has held it in 33 quarters since.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Chatham Capital Group's 13F filing for Q2 2026, filed 13 Jul 2026.